4.5 Review

Identification and consequences of galectin-3 expression in pituitary tumors

Journal

MOLECULAR AND CELLULAR ENDOCRINOLOGY
Volume 326, Issue 1-2, Pages 8-14

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2010.04.026

Keywords

Galectin-3; Pituitary; Tumor; Folliculo-stellate cells; PRL adenoma; ACTH adenoma

Ask authors/readers for more resources

Although the mechanisms regulating pituitary tumor development and progression are still unclear, new information on the molecular mechanisms involved in the pathogenesis of human pituitary tumors have accumulated. Recent evidence suggests that galectin-3 plays an important role in pituitary tumorigenesis and in tumor progression. Galectin-3 is expressed in a variety of tumors and the intensity of expression and localization depend on tumor progression, invasiveness and metastatic potential. Galectin-3 expression has been used as a potential diagnostic and/or prognostic marker in a variety of neoplasms. This review summarizes existing information regarding the structural and functional properties of galectin-3 protein as well as the LGALS3 gene in pituitary tumorigenesis. Given its role in pituitary tumor cell proliferation and in apoptosis, galectin-3 may be a target for the treatment of aggressive pituitary tumors. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available